US Patent 8912194 CDK inhibitor for the treatment of mesothelioma
Patent 8912194 was granted and assigned to Nerviano Medical Sciences on December, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 5 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08912194 CDK inhibitor for the treatment of mesothelioma US Patent 8912194 CDK inhibitor for the treatment of mesothelioma
Infobox
Patent Number
0891219400
Patent Number
891219400
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 8 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
089121940
Date of Patent
December 16, 2014
0Patent Application Number
131309030
Date Filed
November 23, 2009
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
089121940
Date of Patent
December 16, 2014
0Patent Application Number
131309030
Date Filed
November 23, 2009
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 28 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08912194 CDK inhibitor for the treatment of mesothelioma
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08912194
Date of patent
December 16, 2014
Patent application number
13130903
Date Filed
November 23, 2009
Patent primary examiner
Find more entities like US Patent 8912194 CDK inhibitor for the treatment of mesothelioma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
